BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 17872984)

  • 1. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism.
    Williams DR; Warren JD; Lees AJ
    J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):652-5. PubMed ID: 17872984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study.
    Williams DR; Lees AJ
    Lancet Neurol; 2005 Oct; 4(10):605-10. PubMed ID: 16168928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual hallucinations in the differential diagnosis of parkinsonism.
    Bertram K; Williams DR
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):448-52. PubMed ID: 22228724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
    Linder J; Stenlund H; Forsgren L
    Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR; Lees AJ
    Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of pain in atypical parkinsonism: a systematic review and meta-analysis.
    Rana AQ; Qureshi AR; Siddiqui O; Sarfraz Z; Rana R; Shtilbans A
    J Neurol; 2019 Sep; 266(9):2093-2102. PubMed ID: 30238268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
    Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
    J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy.
    Wenning GK; Colosimo C
    Rev Neurol (Paris); 2010 Oct; 166(10):829-33. PubMed ID: 20813385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
    Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
    Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Descriptive epidemiology of parkinsonism in the Canton of Geneva, Switzerland.
    Fleury V; Brindel P; Nicastro N; Burkhard PR
    Parkinsonism Relat Disord; 2018 Sep; 54():30-39. PubMed ID: 29661694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series.
    Geut H; Hepp DH; Foncke E; Berendse HW; Rozemuller JM; Huitinga I; van de Berg WDJ
    Acta Neuropathol Commun; 2020 Mar; 8(1):39. PubMed ID: 32216828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic susceptibility variants in parkinsonism.
    Soto-Ortolaza AI; Ross OA
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S7-11. PubMed ID: 26414118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients.
    Koga S; Aoki N; Uitti RJ; van Gerpen JA; Cheshire WP; Josephs KA; Wszolek ZK; Langston JW; Dickson DW
    Neurology; 2015 Aug; 85(5):404-12. PubMed ID: 26138942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy.
    Boeve BF; Silber MH; Ferman TJ; Lucas JA; Parisi JE
    Mov Disord; 2001 Jul; 16(4):622-30. PubMed ID: 11481685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders.
    Bhidayasiri R; Sringean J; Reich SG; Colosimo C
    Parkinsonism Relat Disord; 2019 Feb; 59():82-92. PubMed ID: 30409560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical parkinsonian syndromes in a North African tertiary referral center.
    Nasri A; Ben Djebara M; Sghaier I; Mrabet S; Zidi S; Gargouri A; Kacem I; Gouider R
    Brain Behav; 2021 Jan; 11(1):e01924. PubMed ID: 33179436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.